LDR | |
01004cam a2200289Ia 4500 |
001 |
|
011399381 |
003 |
|
MiAaHDL |
005 |
|
20141009010000.0 |
006 |
|
m d |
007 |
|
cr bn ---auaua |
008 |
|
000731s2000 mdu f000 0 eng d |
035 |
⊔ |
⊔ |
‡asdr-uiuc4267251
|
035 |
⊔ |
⊔ |
‡9DYZ-6412
|
035 |
⊔ |
⊔ |
‡a(OCoLC)44687234
|
040 |
⊔ |
⊔ |
‡aFDA
‡cFDA
|
049 |
⊔ |
⊔ |
‡aIADA
|
074 |
⊔ |
⊔ |
‡a0467-A-35
|
086 |
0 |
⊔ |
‡aHE 20.3971:H 41
‡zHE 20.3952:D 84/2000
|
245 |
0 |
0 |
‡aHepatitis C.
|
260 |
⊔ |
⊔ |
‡aBethesda, MD (6001 Executive Blvd., Bethesda 20892) :
‡bNational Institute on Drug Abuse, U.S. Dept. of Health and Human Services, National Institutes of Health,
‡c[2000]
|
300 |
⊔ |
⊔ |
‡a[4] p. ;
‡c28 cm.
|
490 |
⊔ |
0 |
‡aNIH publication. ;
‡vno. 00-4663
|
490 |
⊔ |
0 |
‡aCommunity drug alert bulletin
|
500 |
⊔ |
⊔ |
‡aShipping list no.: 2000-0272-P.
|
500 |
⊔ |
⊔ |
‡a"May 2000."
|
500 |
⊔ |
⊔ |
‡aCaption title.
|
504 |
⊔ |
⊔ |
‡aIncludes bibliographical references (p. [4]).
|
538 |
⊔ |
⊔ |
‡aMode of access: Internet.
|
650 |
⊔ |
0 |
‡aHepatitis C.
|
710 |
2 |
⊔ |
‡aNational Institute on Drug Abuse.
|
CID |
⊔ |
⊔ |
‡a011399381
|
DAT |
0 |
⊔ |
‡a20020415165525.0
‡b20141009010000.0
|
DAT |
1 |
⊔ |
‡a20141112162027.0
‡b2023-03-13T18:20:28Z
|
CAT |
⊔ |
⊔ |
‡aSDR-UIUC
‡dUNKNOWN
‡lloader.pl-003-020
|
FMT |
⊔ |
⊔ |
‡aBK
|
HOL |
⊔ |
⊔ |
‡0sdr-uiuc4267251
‡auiug
‡bSDR
‡cUIUC
‡puiug.30112104067845
‡sUIU
‡14267251
|
974 |
⊔ |
⊔ |
‡bUIU
‡cUIUC
‡d20230313
‡sgoogle
‡uuiug.30112104067845
‡y2000
‡rpd
‡qbib
‡tUS fed doc
|